Barclays PLC Grows Position in Altimmune, Inc. (NASDAQ:ALT)
Barclays PLC lifted its position in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 157,528 shares of the company’s stock after purchasing an additional 1,787 shares during the quarter. Barclays PLC’s holdings in Altimmune were worth […]
Barclays PLC lifted its position in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 157,528 shares of the company’s stock after purchasing an additional 1,787 shares during the quarter. Barclays PLC’s holdings in Altimmune were worth […]
